Evidence of a strong association between frequency of self-monitoringof blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 2009-2014

  Miller, Kellee M ^a   Beck, Roy W ^a   Bergenstal, Richard M ^b   Goland, Robin S ^c   Haller, Michael J ^d   McGill, Janet B ^e   Rodriguez, Henry ^f   Simmons, Jill H ^g   Hirsch, Irl B ^h  

^a JAEB CENTER FOR HEALTH RESEARCH   (United States)

^b INTERNATIONAL DIABETES CENTER   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e WASHINGTON UNIVERSITY   (United States)

^f UNIVERSITY OF SOUTH FLORIDA   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CAUCASIAN; CHILD; DISEASE ASSOCIATION; DISEASE REGISTRY; DRUG DELIVERY SYSTEM; FEMALE; HEALTH INSURANCE; HEMOGLOBIN DETERMINATION; HISPANIC; HOUSEHOLD; HUMAN; INCOME; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MONITOR; SELF MONITORING; TREATMENT RESPONSE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84875181139     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1770     Document Type: Article

References (11)

1. Schiffrin A, Belmonte M. Multiple daily self-glucose monitoring: its essential role in long-term glucose control in insulin-dependent diabetic patients treated with pump and multiple subcutaneous injections. Diabetes Care 1982;5:479-484
2. Schütt M, Kern W, Krause U, et al; DPV Initiative. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 2006;114:384-388
3. 1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 2011;12:11-17
4. Haller MJ, Stalvey MS, Silverstein JH. Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004;144: 660-661
5. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LM. Predictors of glycemic control and shortterm adverse outcomes in youth with type 1 diabetes. J Pediatr 2001;139:197-203
6. Pollack A. A panel decides Washington State's healthcare costs. New York Times 2011 Mar 22;Sect. B:1
7. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, Dubose SN, Hall CA; for the T1D Exchange Clinic Network. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012;97:4383-4389
8. The DCCT Research Group. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. Diabetes 1986; 35:530-545
9. The Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 1995;18:361-376
10. The Diabetes Control and Complications TrialResearchGroup. The effect of intensive treatment of diabetes on the development and progression of long-termcomplications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
11. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl. 1):S11-S63